Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen + isosorbide dinitrate dose-titration study in Duchenne muscular dystrophy
2013-004427-37Phase 2Terminated
- Sponsor
- Parent Project
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ibuprofen and isosorbide dinitrate in Duchenne muscular dystrophy (DMD) (4 arms), sponsored by Parent Project. Primary endpoint: Mean change from baseline to end of study in MFM score. Started Sep 2014; status: terminated.
02
Drugs
ibuprofenisosorbide dinitrate
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on 2013-004427-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004427-37.